DOCSLIB.ORG

PNAS 07-04849-SI Table 3. 6-18-2007

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PNAS 07-04849-SI Table 3. 6-18-2007 Table 3. β-arrestin 1-interacting proteins under nonstimulated (-) condition IPI accession Swiss-Prot Number of accession Gene symbol Protein name experiments number number detected Signal transduction Adaptor proteins IPI00293857 P49407 ARRB1 β-arrestin 1 8 IPI00027355 P32121 ARRB2 β-arrestin 2 7 IPI00021353 P10523 SAG S-arrestin (Retinal S-antigen) (48 kDa protein) (S-AG) (Rod photoreceptor arrestin) 4 IPI00003917 P36575 ARR3 X-arrestin (Arrestin-C) (Cone arrestin) (cArr) (Retinal cone arrestin-3) (C-arrestin) 4 IPI00216318 P31946 YWHAB 14-3-3 β/α (14-3-3 protein beta/alpha) (Protein kinase C inhibitor protein 1) (KCIP-1) (Protein 1054) 2 IPI00220642 P61981 YWHAG 14-3-3 γ (14-3-3 protein gamma) (Protein kinase C inhibitor protein 1) (KCIP-1) 2 IPI00018146 P27348 YWHAQ 14-3-3 θ (14-3-3 protein tau) (14-3-3 protein theta) (14-3-3 protein T-cell) (HS1 protein) 2 IPI00216319 Q04917 YWHAH 14-3-3 η (14-3-3 protein eta) (Protein AS1) 2 IPI00000816 P62258 YWHAE 14-3-3 ε (14-3-3 protein epsilon) (14-3-3E) 2 IPI00021263 P63104 YWHAZ 14-3-3 ζ/δ (14-3-3 protein zeta/delta) (Protein kinase C inhibitor protein 1) (KCIP-1) 2 IPI00465275 Q96S59 RANBP9 RanBPM (Ran-binding protein 9) (RanBP9) (RanBP7) (Ran-binding protein M) (BPM90) (BPM-L) 2 Protein kinases IPI00027251 Q15208 STK38 STK38 (Serine/threonine-protein kinase 38) (NDR1 protein kinase) (Nuclear Dbf2-related kinase 1) 2 SCY1-like 2 (SCY1-like 2 protein) (coated vesicle-associated kinase of 104 kDa) (Eukaryotic protein IPI00396218 Q6P3W7 SCYL2 2 kinase family protein) (CDNA FLJ10074 fis, clone HEMBA1001744, weakly similar to SCY1 IPI00013835 Q13574 DGKZ DGK ζ (Diacylglycerol kinase zeta) (Diglyceride kinase zeta) (DGK-zeta) (DAG kinase zeta) 2 DGK ε (Diacylglycerol kinase epsilon) (Diglyceride kinase epsilon) (DGK-epsilon) (DAG kinase IPI00003293 P52429 DGKE 2 epsilon) IPI00027658 P49619 DGKG DGK γ (Diacylglycerol kinase gamma) (Diglyceride kinase gamma) (DGK-gamma) (DAG kinase gamma) 2 p160ROCK ( Rho-associated protein kinase 1) (Rho-associated, coiled- coil-containing protein kinase 1) IPI00022542 Q13464 ROCK1 2 (p160 ROCK-1) (NY-REN-35 antigen) IPI00013981 P07947 YES c-Yes (Proto-oncogene tyrosine-protein kinase Yes)(p61-Yes) 2 IPI00412298 Q13535 ATR Serine/threonine-protein kinase ATR (Ataxia telangiectasia and Rad3-related protein) (FRAP-related 2 Phosphatases IPI00020950 P35813 PPM1A PP2Cα (Protein phosphatase 2C isoform alpha) (PP2C-alpha) (IA) (Protein phosphatase 1A) 2 IPI00026612 O75688 PPM1B PP2Cβ (Protein phosphatase 2C isoform beta) (PP2C-beta) 4 Trafficking IPI00216393 P09496 CLTA Clathrin light chain A 2 IPI00024067 Q00610 CLTC Clathrin heavy chain 2 AP-3 δ1 (Delta-adaptin) (AP-3 complex subunit delta-1) (Adapter-related protein complex 3 subunit IPI00411453 O14617 AP3D1 2 delta-1) (Delta-adaptin 3) (AP-3 complex subunit delta) Gaf-1 (Rab11 family-interacting protein 5) (Rab11-FIP5) (Rab11-interacting protein Rip11) (Gamma- IPI00022033 Q9BXF6 RAB11FIP5 2 SNAP-associated factor 1) (Phosphoprotein pp75) LRP4 (Low-density lipoprotein receptor-related protein 4 precursor) (Multiple epidermal growth factor-like IPI00306851 O75096 LRP4 2 domains 7) LRP-DIT (Low-density lipoprotein receptor-related protein 1B precursor) (Low- density lipoprotein receptor- IPI00032063 Q9NZR2 LRP1B 2 related protein-deleted in tumor) IPI00413140 Q05193 DNM1 dynamin-1 2 G protein- and small GTPase-related IPI00168858 Q5VZ06 RGS3 RGS3S (Regulator of G-protein signaling 3 isoform RGS3S) 2 IPI00005719 P62820 RAB1A Rab-1A (Ras-related protein Rab-1A, member Ras oncogene family) (YPT1-related protein) 2 Other signaling proteins IPI00075248 P62158 CALM1 Calmodulin (CaM) 3 Annexin II (Annexin A2) (Lipocortin II) (Calpactin I heavy chain) (Chromobindin-8) (p36) (Protein I) IPI00455315 P07355 ANXA2 2 (Placental anticoagulant protein IV) (PAP-IV) IPI00419647 Q9Y6C5 PTCH2 Patched 2 (Protein patched homolog 2) (PTC2) 2 IPI00414286 O75056 SDC3 Syndecan-3 (SYND3) 2 Nucleic acid binding DNA binding, chromatin structure and cell cycle regualtion IPI00217465 P16403 HIST1H1C Histone H1.2 (Histone H1d) 4 IPI00152785 P23527 HIST1H2BO Histone H2B (Histone H2B type 1-O) (H2B.n) (H2B/n) (H2B.2) 2 IPI00453473 P62805 HIST1H4A Histone H4 2 IPI00216730 Q8IUE6 HIST2H2AB Histone H2A (Histone H2A type 2-B) 2 IPI00219038 P84243 H3F3A Histone H3.3 (H3 histone, family 3A) 2 Transcription factor and transcription regulatory protein Nopp 140 (Nucleolar phosphoprotein p130) (Nucleolar 130 kDa protein) (140 kDa nucleolar IPI00292387 Q14978 NOLC1 8 phosphoprotein) (Nucleolar and coiled-body phosphoprotein 1) IPI00298696 Q13428 TCOF1 Treacle (Treacher collins franceschetti syndrome 1) 8 JBP1 (Protein arginine N-methyltransferase 5) (Shk1 kinase-binding protein 1 homolog) (SKB1Hs) IPI00441473 O14744 PRMT5 5 (Jak-binding protein 1) (72 kDa ICln-binding protein) IPI00549248 P06748 NPM1 Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Numatrin) (Nucleolar protein NO38) 2 IPI00031960 O95602 POLR1A RPA194 (DNA-directed RNA polymerase I largest subunit) (RNA polymerase I 194 kDa subunit) 3 IPI00005179 O15160 POLR1C RPA40 (DNA-directed RNA polymerase I 40 kDa polypeptide) 2 PAF53 (DNA-directed RNA polymerase I-associated factor 53 kDa subunit) (RNA polymerase I IPI00478729 Q9GZS1 POLR1E 2 polypeptide E) (RNA polymerase I- associated factor 1) PAF49 (RNA polymerase I-associated factor PAF49) (Antisense ERCC1) (Anti-sense to ERCC-1 protein) IPI00012788 O15446 CD3EAP 3 (ASE-1) (CD3-epsilon-associated protein) (CD3E-associated protein) (CAST) ZNF265 (Zinc finger protein 265) (Zinc finger Ran-binding domain-containing protein 2) (Zinc IPI00029400 O95218 ZNF265 8 finger, splicing) Trap150 (Thyroid hormone receptor-associated protein 3) (Thyroid hormone receptor-associated IPI00104050 Q9Y2W1 THRAP3 3 protein complex 150 kDa component) Thymopoietin (Thymopoietin α) (Lamina-associated polypeptide 2 isoform alpha) (Thymopoietin isoform IPI00216230 P42166 TMPO 2 alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) YB-1 (Y-box transcription factor) (Nuclease sensitive element-binding protein 1) (Y-box-binding IPI00031812 P67809 YBX1 protein 1) (Y-box transcription factor) (CCAAT-binding transcription factor I subunit A) (CBF-A) 2 (Enhancer factor I subunit A) (EFI-A) (DNA-binding protein B) (DBPB) Tho4 (THO complex subunit 4) (Ally of AML-1 and LEF-1) (Transcriptional coactivator Aly/REF) IPI00328840 Q86V81 THOC4 2 (bZIP-enhancing factor BEF) RNA processing and ribonucleoprotein Nop10 (H/ACA ribonucleoprotein complex subunit 3) (Nucleolar protein family A member 3) IPI00032853 Q9NPE3 NOLA3 2 (snoRNP protein NOP10) IPI00549342 Q5JRR2 RBM10 RNA binding motif protein 10 4 SAP 145 (Splicing factor 3B subunit 2) (Spliceosome-associated protein 145) (SF3b150) (Pre- IPI00221106 Q13435 SF3B2 2 mRNA-splicing factor SF3b 145 kDa subunit) IPI00604620 P19338 NCL Nucleolin (Protein C23) 3 SMD1 (Sm-D1) (Small nuclear ribonucleoprotein Sm D1) (snRNP core protein D1) (Sm-D IPI00302850 P62314 SNRPD1 2 autoantigen) SRRM2 (splicing coactivator subunit SRm300) (Serine/arginine repetitive matrix protein 2) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (Ser/Arg- related IPI00782992 Q9UQ35 SRRM2 2 nuclear matrix protein) (SR-related nuclear matrix protein of 300 kDa) (300 kDa nuclear matrix antigen) IPI00171903 P52272 HNRPM hnRNP M (Heterogeneous nuclear ribonucleoprotein M) 3 hnRNP K (Heterogeneous nuclear ribonucleoprotein K) (Transformation up-regulated nuclear IPI00216049 P61978 HNRPK 2 protein) (TUNP) Dyskerin (H/ACA ribonucleoprotein complex subunit 4) (Dyskerin) (Nopp140-associated protein of IPI00221394 O60832 DKC1 2 57 kDa) IPI00419373 P51991 HNRPA3 hnRNP A3 (Heterogeneous nuclear ribonucleoprotein A3) 3 Protein biosynthesis IPI00012079 P23588 EIF4B eIF-4B (Eukaryotic translation initiation factor 4B) 3 IPI00014424 Q05639 EEF1A2 eEF1A-2 (Elongation factor 1-alpha 2) (EF-1-alpha-2) (Elongation factor 1 A-2) (Statin S1) 3 Ribosomal protein L22 (60S ribosomal protein L22) (Epstein-Barr virus small RNA-associated IPI00219153 P35268 RPL22 3 protein) (EBER-associated protein) (EAP) (Heparin-binding protein HBp15) IPI00419880 P61247 RPS3A Ribosomal protein S3a (40S ribosomal protein S3a) 2 IPI00221093 P08708 RPS17 Ribosomal protein S17 (40S ribosomal protein S17) 2 IPI00179713 Q9Y6M1 IGF2BP2 IMP-2 (IGF-II mRNA-binding protein 2) (p62)(insulin-like growth factor 2 mRNA binding protein 2) 2 Cellular organization Cytoskeleton constituent proteins IPI00021428 P68133 ACTA1 Actin α-1 (Alpha actin 1) (Actin, alpha skeletal muscle) 7 Tubulin α-1 (Tubulin alpha-1 chain) (Alpha-tubulin 1) (Testis-specific alpha- tubulin) (Tubulin H2- IPI00007750 P68366 TUBA1 2 alpha) IPI00179709 Q13748 TUBA2 Tubulin α-2 (Tubulin alpha-2 chain) (Alpha-tubulin 2) 2 IPI00218343 Q9BQE3 TUBA6 Tubulin α-6 (Tubulin alpha-6 chain) (Alpha-tubulin 6) 3 IPI00011654 P07437 TUBB5 Tubulin β-5 (Tubulin beta chain) (Tubulin beta-5 chain) 4 IPI00418471 P08670 VIM Vimentin 4 IPI00013475 Q13885 TUBB2 Tubulin β-2A (Tubulin beta-2A chain) 2 Cytoskeleton accessory proteins Filamin A (Alpha-filamin) (Filamin-1) (Endothelial actin-binding protein) (Actin-binding protein 280) IPI00333541 P21333 FLNA 4 (ABP-280) (Nonmuscle filamin) IPI00026314 P06396 GSN Gelsolin (Actin-depolymerizing factor) (ADF) (Brevin) (AGEL) 3 IPI00008918 Q9UHB6 LIMA1 Eplin (Epithelial protein lost in neoplasm) (LIM domain and actin-binding protein 1) 3 IPI00166518 Q6WCQ1 RHOIP3 p116Rip (Myosin phosphatase-Rho interacting protein) (Rho-interacting protein 3) (M-RIP) (RIP3) 2
Load more

Recommended publications
  • Oup Radres Rrz001 289..297 ++
    Journal of Radiation Research, Vol. 60, No. 3, 2019, pp. 289–297 doi: 10.1093/jrr/rrz001 Advance Access Publication: 26 February 2019 Ionizing radiation affects the composition of the proteome of extracellular vesicles released by head-and-neck cancer cells in vitro Agata Abramowicz1, Anna Wojakowska1, Lukasz Marczak2, Malgorzata Lysek-Gladysinska3, Mateusz Smolarz1, Michael D. Story4, Joanna Polanska5, Piotr Widlak1 and Monika Pietrowska1,* 1Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska–Curie Institute–Oncology Center, Gliwice Branch, ul. Wybrzeze Armii Krajowej 15, 44-101 Gliwice, Poland 2Institute of Bioorganic Chemistry, Polish Academy of Sciences, ul. Noskowskiego 12/14, 61-704 Poznan, Poland 3The Jan Kochanowski University in Kielce, Institute of Biology, Department of Cell Biology and Electron Microscopy, ul. Swietokrzyska 15, 25-406 Kielce, Poland 4University of Texas Southwestern Medical Center, Department of Radiation Oncology, Division of Molecular Radiation Biology, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA 5Faculty of Automatic Control, Electronics and Computer Science, Silesian University of Technology, ul. Akademicka 16, 44-100 Gliwice, Poland *Corresponding author. Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska–Curie Institute–Oncology Center, Gliwice Branch, ul. Wybrzeze Armii Krajowej 15, 44-101 Gliwice, Poland. Tel: +0048-32-278-9627; Fax: +0048-32-278-9840; Email: [email protected] (Received 29 August 2018; revised 7 November 2018; editorial decision 8 January 2019) ABSTRACT Exosomes and other extracellular vesicles are key players in cell-to-cell communication, and it has been proposed that they are involved in different aspects of the response to ionizing radiation, including transmitting the radiation-induced bystander effect and mediating radioresistance.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Supporting Information
    Supporting Information Figure S1. The functionality of the tagged Arp6 and Swr1 was confirmed by monitoring cell growth and sensitivity to hydeoxyurea (HU). Five-fold serial dilutions of each strain were plated on YPD with or without 50 mM HU and incubated at 30°C or 37°C for 3 days. Figure S2. Localization of Arp6 and Swr1 on chromosome 3. The binding of Arp6-FLAG (top), Swr1-FLAG (middle), and Arp6-FLAG in swr1 cells (bottom) are compared. The position of Tel 3L, Tel 3R, CEN3, and the RP gene are shown under the panels. Figure S3. Localization of Arp6 and Swr1 on chromosome 4. The binding of Arp6-FLAG (top), Swr1-FLAG (middle), and Arp6-FLAG in swr1 cells (bottom) in the whole chromosome region are compared. The position of Tel 4L, Tel 4R, CEN4, SWR1, and RP genes are shown under the panels. Figure S4. Localization of Arp6 and Swr1 on the region including the SWR1 gene of chromosome 4. The binding of Arp6- FLAG (top), Swr1-FLAG (middle), and Arp6-FLAG in swr1 cells (bottom) are compared. The position and orientation of the SWR1 gene is shown. Figure S5. Localization of Arp6 and Swr1 on chromosome 5. The binding of Arp6-FLAG (top), Swr1-FLAG (middle), and Arp6-FLAG in swr1 cells (bottom) are compared. The position of Tel 5L, Tel 5R, CEN5, and the RP genes are shown under the panels. Figure S6. Preferential localization of Arp6 and Swr1 in the 5′ end of genes. Vertical bars represent the binding ratio of proteins in each locus.
    [Show full text]
  • Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
    0031-6997/10/6202-305–330$20.00 PHARMACOLOGICAL REVIEWS Vol. 62, No. 2 U.S. Government work not protected by U.S. copyright 2436/3586110 Pharmacol Rev 62:305–330, 2010 Printed in U.S.A. ASSOCIATE EDITOR: DAVID R. SIBLEY Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling LOUIS M. LUTTRELL AND DIANE GESTY-PALMER Departments of Medicine and Biochemistry & Molecular Biology, Medical University of South Carolina (L.M.L.) and the Ralph H. Johnson Veterans Affairs Medical Center (L.M.L.), Charleston, South Carolina; and Department of Medicine, Duke University Medical Center (D.G.-P.) and the Durham Veterans Affairs Medical Center (D.G.-P.), Durham, North Carolina Abstract ................................................................................ 305 I. Introduction............................................................................. 306 II. The duality of arrestin function ........................................................... 307 A. Arrestin-dependent desensitization and endocytosis...................................... 307 B. Arrestins as signal transducers ........................................................ 308 III. Arrestin signaling in vitro ................................................................ 310 A. Diversity in arrestin signaling ......................................................... 310 B. Receptor desensitization and second messenger production ............................... 311 C. Receptor endocytosis and vesicle trafficking ............................................
    [Show full text]
  • Ncounter® Mouse Autoimmune Profiling Panel - Gene and Probe Details
    nCounter® Mouse AutoImmune Profiling Panel - Gene and Probe Details Official Symbol Accession Alias / Previous Symbol Official Full Name Other targets or Isoform Information AW208573,CD143,expressed sequence AW208573,MGD-MRK- Ace NM_009598.1 1032,MGI:2144508 angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 2610036I19Rik,2610510L13Rik,Acinus,apoptotic chromatin condensation inducer in the nucleus,C79325,expressed sequence C79325,MGI:1913562,MGI:1919776,MGI:2145862,mKIAA0670,RIKEN cDNA Acin1 NM_001085472.2 2610036I19 gene,RIKEN cDNA 2610510L13 gene apoptotic chromatin condensation inducer 1 Acp5 NM_001102405.1 MGD-MRK-1052,TRACP,TRAP acid phosphatase 5, tartrate resistant 2310066K23Rik,AA960180,AI851923,Arp1b,expressed sequence AA960180,expressed sequence AI851923,MGI:2138136,MGI:2138359,RIKEN Actr1b NM_146107.2 cDNA 2310066K23 gene ARP1 actin-related protein 1B, centractin beta Adam17 NM_001277266.1 CD156b,Tace,tumor necrosis factor-alpha converting enzyme a disintegrin and metallopeptidase domain 17 ADAR1,Adar1p110,Adar1p150,AV242451,expressed sequence Adar NM_001038587.3 AV242451,MGI:2139942,mZaADAR adenosine deaminase, RNA-specific Adora2a NM_009630.2 A2AAR,A2aR,A2a, Rs,AA2AR,MGD-MRK-16163 adenosine A2a receptor Ager NM_007425.2 RAGE advanced glycosylation end product-specific receptor AI265500,angiotensin precursor,Aogen,expressed sequence AI265500,MGD- Agt NM_007428.3 MRK-1192,MGI:2142488,Serpina8 angiotensinogen (serpin peptidase inhibitor, clade A, member 8) Ah,Ahh,Ahre,aromatic hydrocarbon responsiveness,aryl hydrocarbon
    [Show full text]
  • A Complex Structure of Arrestin-2 Bound to a G Protein-Coupled Receptor
    bioRxiv preprint doi: https://doi.org/10.1101/822957; this version posted October 29, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. A complex structure of arrestin-2 bound to a G protein-coupled receptor Wanchao Yin1*, Zhihai Li1,2*, Mingliang Jin3*, Yu-Ling Yin1, 4*, Parker W. de Waal5, Kuntal Pal5,6, Yanting Yin1,5, Xiang Gao5, Yuanzheng He5,7, Jing Gao1, Xiaoxi Wang1, Yan Zhang8, Hu Zhou1, Karsten Melcher5, Yi Jiang1, Yao Cong3+, X. Edward Zhou5+, Xuekui Yu1,2+, H. Eric Xu1, 5+ 1The CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. 2Cryo-Electron Microscopy Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. 3National Center for Protein Science Shanghai, State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai 201210, China. 4University of Chinese Academy of Sciences, Beijing 100049, China. 5Center for Cancer and Cell Biology, Program for Structural Biology, Van Andel Research Institute, Grand Rapids, MI 49503, USA. 6Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, India. 7Laboratory of Receptor Structure and Signaling, HIT Center for Life Science, Harbin Institute of Technology, Harbin 150001, China. 8Department of Pathology of Sir Run Run Shaw Hospital and Department of Biophysics, Zhejiang University School of Medicine, Hangzhou 310058, China.
    [Show full text]
  • An Auxin Minimum Triggers the Developmental Switch from Cell Division to Cell Differentiation in the Arabidopsis Root
    AN AUXIN MINIMUM TRIGGERS THE DEVELOPMENTAL SWITCH FROM CELL DIVISION TO CELL DIFFERENTIATION IN THE ARABIDOPSIS ROOT Riccardo Di Mambro1,*,#, Micol De Ruvo1,6,7,*, Elena Pacifici1, Elena Salvi1, Ross Sozzani2, Philip N. Benfey3, Wolfgang Busch4, Ondrej Novak5, Karin Ljung5, Luisa Di Paola6, Athanasius F. M. Marée7, Paolo Costantino1, Verônica A. Grieneisen7,†, Sabrina Sabatini1,8,†. 1: Dipartimento di Biologia e Biotecnologie, Laboratory of Functional Genomics and Proteomics of Model Systems, Università di Roma, Sapienza - via dei Sardi, 70 - 00185 Rome, Italy. 2: Department of Plant and Microbial Biology, North Carolina State University, Raleigh, NC, United States. 3: Department of Biology and Howard Hughes Medical Institute, Duke University, Durham, North Carolina 27708, USA. 4: Gregor Mendel Institute (GMI), Austrian Academy of Sciences, Vienna Biocenter (VBC), Dr. Bohr-Gasse 3, 1030 Vienna, Austria. 5: Umeå Plant Science Centre, Department of Forest Genetics and Plant Physiology, Swedish University of Agricultural Sciences, SE-901 83 Umeå, Sweden. 6: Unit of Chemical-physics Fundamentals in Chemical Engineering, Department of Engineering, Università Campus Bio-Medico di Roma, via Álvaro del Portillo 21, 00128 Rome, Italy. 7: Computational and Systems Biology, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK. 8: Istituto Pasteur-Fondazione Cenci Bolognetti. * These authors contributed equally to this work # Present address: Dipartimento di Biologia, Università di Pisa - via Ghini, 13 - 56126 Pisa, Italy. † Authors for correspondence Tel: 39-06-49917916 Fax: 39-06-49917594 e-mail: [email protected] e-mail: [email protected] 1 Supporting Information Appendix Materials and methods Root Length, Meristem Size and Cell Size Analysis For root length measurements, plates were photographed and the resulting images were analysed using the image analysis software ImageJ 1.47v available online (http://rsbweb.nih.gov/ij/).
    [Show full text]
  • The Human Gene Connectome As a Map of Short Cuts for Morbid Allele Discovery
    The human gene connectome as a map of short cuts for morbid allele discovery Yuval Itana,1, Shen-Ying Zhanga,b, Guillaume Vogta,b, Avinash Abhyankara, Melina Hermana, Patrick Nitschkec, Dror Friedd, Lluis Quintana-Murcie, Laurent Abela,b, and Jean-Laurent Casanovaa,b,f aSt. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065; bLaboratory of Human Genetics of Infectious Diseases, Necker Branch, Paris Descartes University, Institut National de la Santé et de la Recherche Médicale U980, Necker Medical School, 75015 Paris, France; cPlateforme Bioinformatique, Université Paris Descartes, 75116 Paris, France; dDepartment of Computer Science, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel; eUnit of Human Evolutionary Genetics, Centre National de la Recherche Scientifique, Unité de Recherche Associée 3012, Institut Pasteur, F-75015 Paris, France; and fPediatric Immunology-Hematology Unit, Necker Hospital for Sick Children, 75015 Paris, France Edited* by Bruce Beutler, University of Texas Southwestern Medical Center, Dallas, TX, and approved February 15, 2013 (received for review October 19, 2012) High-throughput genomic data reveal thousands of gene variants to detect a single mutated gene, with the other polymorphic genes per patient, and it is often difficult to determine which of these being of less interest. This goes some way to explaining why, variants underlies disease in a given individual. However, at the despite the abundance of NGS data, the discovery of disease- population level, there may be some degree of phenotypic homo- causing alleles from such data remains somewhat limited. geneity, with alterations of specific physiological pathways under- We developed the human gene connectome (HGC) to over- come this problem.
    [Show full text]
  • Genome-Wide Screening Identifies Genes and Biological Processes
    Louisiana State University LSU Digital Commons LSU Doctoral Dissertations Graduate School 10-12-2018 Genome-Wide Screening Identifies Genes and Biological Processes Implicated in Chemoresistance and Oncogene-Induced Apoptosis Tengyu Ko Louisiana State University and Agricultural and Mechanical College, [email protected] Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations Part of the Cancer Biology Commons, Cell Biology Commons, and the Genomics Commons Recommended Citation Ko, Tengyu, "Genome-Wide Screening Identifies Genes and Biological Processes Implicated in Chemoresistance and Oncogene- Induced Apoptosis" (2018). LSU Doctoral Dissertations. 4715. https://digitalcommons.lsu.edu/gradschool_dissertations/4715 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please [email protected]. GENOME-WIDE SCREENING IDENTIFIES GENES AND BIOLOGICAL PROCESSES IMPLICATED IN CHEMORESISTANCE AND ONCOGENE- INDUCED APOPTOSIS A Dissertation Submitted to the Graduate Faculty of the Louisiana State University and Agricultural and Mechanical College in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical and Veterinary Medical Sciences through the Department of Comparative Biomedical Sciences by Tengyu Ko B.S., University of California, Santa Barbara 2010 December 2018 ACKNOWLEDGEMENTS I would like to express my sincerest gratitude to my major supervisor Dr. Shisheng Li for giving me the opportunity to join his team and the freedom to pursue projects. I appreciate all of his thoughts and efforts. Truly, none of these findings would be possible without his supervisions, supports, insightful discussions, and patience.
    [Show full text]
  • (Raav)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays
    International Journal of Molecular Sciences Review Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays Thilo M. Buck 1 and Jan Wijnholds 1,2,* 1 Department of Ophthalmology, Leiden University Medical Center (LUMC), 2333 ZC Leiden, The Netherlands; [email protected] 2 Netherlands Institute of Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW), 1105 BA Amsterdam, The Netherlands * Correspondence: [email protected]; Tel.: +31-71-52-69269 Received: 20 May 2020; Accepted: 10 June 2020; Published: 12 June 2020 Abstract: Inherited retinal dystrophies and optic neuropathies cause chronic disabling loss of visual function. The development of recombinant adeno-associated viral vectors (rAAV) gene therapies in all disease fields have been promising, but the translation to the clinic has been slow. The safety and efficacy profiles of rAAV are linked to the dose of applied vectors. DNA changes in the rAAV gene cassette affect potency, the expression pattern (cell-specificity), and the production yield. Here, we present a library of rAAV vectors and elements that provide a workflow to design novel vectors. We first performed a meta-analysis on recombinant rAAV elements in clinical trials (2007–2020) for ocular gene therapies. We analyzed 33 unique rAAV gene cassettes used in 57 ocular clinical trials. The rAAV gene therapy vectors used six unique capsid variants, 16 different promoters, and six unique polyadenylation sequences. Further, we compiled a list of promoters, enhancers, and other sequences used in current rAAV gene cassettes in preclinical studies. Then, we give an update on pro-viral plasmid backbones used to produce the gene therapy vectors, inverted terminal repeats, production yield, and rAAV safety considerations.
    [Show full text]
  • Research Article Complex and Multidimensional Lipid Raft Alterations in a Murine Model of Alzheimer’S Disease
    SAGE-Hindawi Access to Research International Journal of Alzheimer’s Disease Volume 2010, Article ID 604792, 56 pages doi:10.4061/2010/604792 Research Article Complex and Multidimensional Lipid Raft Alterations in a Murine Model of Alzheimer’s Disease Wayne Chadwick, 1 Randall Brenneman,1, 2 Bronwen Martin,3 and Stuart Maudsley1 1 Receptor Pharmacology Unit, National Institute on Aging, National Institutes of Health, 251 Bayview Boulevard, Suite 100, Baltimore, MD 21224, USA 2 Miller School of Medicine, University of Miami, Miami, FL 33124, USA 3 Metabolism Unit, National Institute on Aging, National Institutes of Health, 251 Bayview Boulevard, Suite 100, Baltimore, MD 21224, USA Correspondence should be addressed to Stuart Maudsley, [email protected] Received 17 May 2010; Accepted 27 July 2010 Academic Editor: Gemma Casadesus Copyright © 2010 Wayne Chadwick et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Various animal models of Alzheimer’s disease (AD) have been created to assist our appreciation of AD pathophysiology, as well as aid development of novel therapeutic strategies. Despite the discovery of mutated proteins that predict the development of AD, there are likely to be many other proteins also involved in this disorder. Complex physiological processes are mediated by coherent interactions of clusters of functionally related proteins. Synaptic dysfunction is one of the hallmarks of AD. Synaptic proteins are organized into multiprotein complexes in high-density membrane structures, known as lipid rafts. These microdomains enable coherent clustering of synergistic signaling proteins.
    [Show full text]
  • ARR3 Antibody Cat
    ARR3 Antibody Cat. No.: 7643 ARR3 Antibody Immunofluorescence of ARR3 in mouse spleen tissue with ARR3 antibody at 20 μg/ml. Immunohistochemistry of ARR3 in mouse spleen tissue with ARR3 antibody at 2 μg/ml. Green: ARR3 Antibody (7643) Blue: DAPI staining Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human, Mouse, Rat ARR3 antibody was raised against a 17 amino acid peptide near the carboxy terminus of human ARR3. IMMUNOGEN: The immunogen is located within the last 50 amino acids of ARR3. TESTED APPLICATIONS: ELISA, IF, IHC-P, WB September 29, 2021 1 https://www.prosci-inc.com/arr3-antibody-7643.html ARR3 antibody can be used for detection of ARR3 by Western blot at 0.5 - 1 μg/ml. Antibody can also be used for immunohistochemistry starting at 2 μg/mL. For immunofluorescence start at 20 μg/mL. APPLICATIONS: Antibody validated: Western Blot in mouse samples; Immunohistochemistry in mouse samples and Immunofluorescence in mouse samples. All other applications and species not yet tested. ARR3 antibody is human, mouse and rat reactive. At least three isoforms of ARR3 are SPECIFICITY: known to exist. This antibody is predicted to not cross-react with other members of the arrestin protein family. POSITIVE CONTROL: 1) Cat. No. 1287 - EL4 Cell Lysate Predicted: 43 kDa PREDICTED MOLECULAR WEIGHT: Observed: 47 kDa Properties PURIFICATION: ARR3 antibody is affinity chromatography purified via peptide column. CLONALITY: Polyclonal ISOTYPE: IgG CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: ARR3 antibody is supplied in PBS containing 0.02% sodium azide. CONCENTRATION: 1 mg/mL ARR3 antibody can be stored at 4˚C for three months and -20˚C, stable for up to one STORAGE CONDITIONS: year.
    [Show full text]